Search
  1. Home
  2. East Africa
  3. Kenya

Phase-two HIV/AIDS vaccine trials begin

    JOHANNESBURG
    Phase-two trials of Kenya's HIV/AIDS vaccine are underway, local newspaper the East African Standard reported on Thursday. Phase-one safety trials in the Kenya AIDS Vaccine Initiative (KAVI) were started two years ago. KAVI's lead researcher, Prof Job Bwayo, said while the initial phase was tested in two groups of 18 volunteers each, the second phase would involve between 100 and 1,000 volunteers. Bwayo said with the success of the initial phase, he was hopeful that phase-three trials - the results stage - would begin sooner than expected.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join